Adjunctive bright light in non-seasonal major depression

Acta Psychiatrica Scandinavica, Supplement

Volumn 110, Issue 425, 2004, Pages 7-28

  Martiny, Klaus ^a  

^a FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

Author keywords

Light therapy; Melancholia; Non seasonal depression; Randomized controlled trial; Self assessment

Indexed keywords

ANTIDEPRESSANT AGENT; MIANSERIN; OXAZEPAM; SERTRALINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DOUBLE BLIND PROCEDURE; EYE IRRITATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; NAUSEA; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RED LIGHT; SEASONAL AFFECTIVE DISORDER; SEASONAL VARIATION; SELF EVALUATION; SIDE EFFECT; VOMITING; WHITE LIGHT; ALGORITHM; DEPRESSION; MULTIMODALITY CANCER THERAPY; CONFERENCE PAPER; DISEASE SEVERITY; LIGHT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; ALGORITHMS; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHOTOTHERAPY; SERTRALINE;

EID: 9344235066     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00460_2.x     Document Type: Article

References (90)

1. BECH P. Pharmacological treatment of depressive disorders: a review. In: MAJ M, SARTORIUS N, eds. Depressive disorders, 2nd edn. Chichester: John Wiley, 2002:89-128.
2. MAGNUSSON A. Historical excerpts. In: PARTONEN T, MAGNUSSON A, eds. Seasonal affective disorder, practice and research. Oxford: Oxford University Press, 2001.
3. Hippocrates. On airs, waters, and places. 400 B.C. Translated by Francis Adams. London: Printed for the Sydenham Society, 1849.
4. LAWRENCE G. Tools of the trade: the Finsen light. Lancet 2002;359:1784.
5. LEWY AJ, WEHR TA, GOODWIN FK, NEWSOME DA, MARKEY SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-1269.
6. KRIPKE DF, MULLANEY DJ, ATKINSON M, WOLF S. Circadian rhythm disorders in manic-depressives. Biol Psychiatr 1978;13:335-351.
7. KRIPKE, D. Photoperiodic mechanisms for depression and its treatment. Amsterdam: Elsevier, 1981.
8. ROSENTHAL NE, LEWY AJ, WEHR TA, KERN HE, GOODWIN FK. Seasonal cycling in a bipolar patient. Psychiatry Res 1983;8:25-31.
9. ROSENTHAL NE, SACK DA, GILLIN JC et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984;41:72-80.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Third edition, revised (DSM-III-R). Washington DC: American Psychiatric Association, 1987.
11. PARTONEN T, ROSENTHAL EN. Symptoms and course of illness. In: PARTONEN T, MAGNUSSON A, eds. Seasonal affective disorder, practice and research. Oxford: Oxford University Press, 2001.
12. ROSENTHAL NE, BRADT GJ, WEHR TA. Seasonal pattern assessment questionnaire (SPAQ). National Institute of Mental Health: Bethesda MD, 1984.
13. KASPER S, WEHR TA, BARTKO JJ, GAIST PA, ROSENTHAL NE. Epidemiological findings of seasonal changes in mood and behaviour: a telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry 1989;46:823-833.
14. WILLIAMS JB, LINK MJ, ROSENTHAL NE, TERMAN M. Structured interview guide for the Hamilton depression rating scale, seasonal affective disorders version (SIGH-SAD). New York: New York Psychiatric Institute, 1988.
15. MOORE RY. Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. Fed Proc 1983;42:2783-2789.
16. LEWY AJ, WEHR TA, GOODWIN FK, NEWSOME DA, MARKEY SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-1269.
17. BRAINARD GC, LEWY AJ, MENAKER M et al. Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers. Brain Res 1988;454:212-218.
18. MÖLLER M, BAERES FM. The anatomy and innervation of the mammalian pineal gland. Cell Tiss Re 2002;309:139-150.
19. PARTONEN T, ROSENTHAL EN. Symptoms and course of illness. In: PARTONEN T, MAGNUSSON A, eds. Oxford: Oxford University Press, 2001.
20. LAM R. Seasonal affective disorder and beyond. Light treatment for SAD and non-SAD conditions. Washington DC: American Psychiatric Press, 1998.
21. OREN DA. Retinal melatonin and dopamine in seasonal affective disorder. J Neural Transm Gen Sect 1991;83: 85-95.
22. LEWY AJ, SACK RL, SINGER CM, WHITE DM, HOBAN TM. Winter depression and the phase-shift hypothesis for bright light's therapeutic effects: history, theory, and experimental evidence. J Biol Rhythms 1988;3:121-134.
23. WETTERBERG L. Light therapy of depression; basal and clinical aspects. Pharmacol Toxicol 1992;71(Suppl. 1):96-106.
24. MAGNUSSON A, BOIVIN D. Seasonal affective disorder: an overview. Chronobiol Int 2003;20:189-207.
25. LEVITT AJ, LAM R, GHADIRIAN A. IN: LAM R, LEVITT A, eds. Canadian consensus guidelines for the treatment of seasonal affective disorder. Canada: Vancouver, 1999.
26. LAMBERT GW, REID C, KAYE DM, JENNINGS GL, ESLER MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002;360:1840-1842.
27. WIRZ-JUSTICE A. Biological rhythms and depression. Schweiz Arch Neurol Psychiatr 1986;137:87-96.
28. NEUMEISTER A, TURNER EH, MATTHEWS JR et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 1998;55:524-530.
29. WEHR TA, DUNCAN WC JR, SHER L et al. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry 2001;58:1108-1114.
30. HATTAR S, LIAO HW, TAKAO M, BERSON DM, YAU KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002;295:1065-1070.
31. WIRZ-JUSTICE A, BUCHELI C, GRAW P, KIELHOLZ P, FISCH HU, WOGGON B. Light treatment of seasonal affective disorder in Switzerland. Acta Psychiatr Scand 1986;74:193-204.
32. KRIPKE DF. Light treatment for nonseasonal depression: speed, efficacy and combined treatment. J Affect Disord 1998;49:109-117.
33. HEIM M. Effectiveness of bright light therapy in cyclothymic axis syndromes-a cross-over study in comparison with partial sleep deprivation. Psychiatr Neurol Med Psychol (Leipz) 1988;40:269-277.
34. PRASKO J, HORACEK J, KLASCHKA J, KOSOVA J, ONDRACKOVA I, SIPEK J. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuroendocrinol Lett 2002;23:109-113.
35. YAMADA N, MARTIN-IVERSON MT, DAIMON K, TSUJIMOTO T, TAKAHASHI S. Clinical and chronobiological effects of light therapy on nonseasonal affective disorders. Biol Psychiatry 1995;37:866-873.
36. BRADLEY N, GAYNES R, EKSTROM D et al. Phototherapy: a systematic review of the evidence. Poster presented at APA, San Francisco 2003. Chapel Hill, NC: University of North Carolina at Chapel Hill, 2003.
37. BENEDETTI F, COLOMBO C, PONTIGGIA A, BERNASCONI A, FLORITA M, SMERALDI E. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry 2003;64:648-653.
38. MÜLLER JM, SEIFRITZ E, HATZINGER M, HEMMETER U, HOLSBOER-TRACHSLER E. Side effects of adjunct light therapy in patients with major depression. Eur Arch Psychiatry Neurosci 1997;247:252-258.
39. HOLSBOER-TRACHSLER E, HEMMETER U, HATZINGER M, SEIFIRTZ E, GERHAR U, HOBI V. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - neurobiological and psychometric assessment of course. J Psychiatr Res 1994;28:381-399.
40. FRITZSCHE M, HELLER R, HILL H, KICK H. Sleep deprivation as a predictor of response to light therapy in major depression. J Affect Disord 2001;62:207-215.
41. NEUMEISTER A, GOESSLER R, LUCHT M, KAPITANY T, BARNAS C, KASPER S. Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation. Biol Psychiatry 1996;39:16-21.
42. BEAUCHEMIN KM, HAYS P. Phototherapy is a useful adjunct in the treatment of depressed in-patients. Acta Psychiatr Scand 1997;95:424-427.
43. TERMAN M, TERMAN J, QUITKIN F, MCGRATH P, STEWART J, RAFFERTY B. Light treatment for Seasonal Affective Disorder. A review of efficacy. Neuropsychopharmacol 1989; 2:1-22.
44. MARTINY K, LUNDE M, SIMONSEN C et al. Relapse prevention with citalopram in SAD patients responding to one week of bright light treatment. Acta Psychiatr Scand 2004;109:230-234.
45. LABBATE LA, LAFER B, THIBAULT A, SACHS GS. Side effects induced by bright light treatment for seasonal affective disorder. J Clin Psychiatry 1994;55:189-91.
46. TERMAN M, TERMAN JS. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60:799-808.
47. WIRZ-JUSTICE A, GRAW P, KRAUCHI K et al. 'Natural' light treatment of seasonal affective disorder. J Affect Disord 1995;37:109-20.
48. WESSON VA, LEVITT AJ. Light therapy for seasonal affective disorder. In: LAM R, ed. Seasonal affective disorder and beyond. Light treatment for SAD and non-SAD conditions. Washington DC: American Psychiatric Press, 1998:45-90.
49. KRIPKE F, MULLANEY D. Controlled trial of bright light for Nonseasonal Major Depressive Disorder. Biol Psychiatry 1992;31:119-134.
50. FABRE LF, ABUZZAHAB FS, AMIN M et al. sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38:592-602.
51. SHEEHAN DV, LECRUBIER Y, HARNETT SHEEHAN K et al. The Mini International NeuropsychiatriC Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 1998;59(Suppl. 20):22-33.
52. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth revised edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
53. THOMPSON C, THOMPSON S, SMITH R. Prevalence of seasonal affective disorder in primary care; a comparison of the seasonal health questionnaire and the seasonal pattern assessment questionnaire. J Affect Disord 2004;78:219-226.
54. CHRISTENSEN EM, LARSEN JK, GJERRIS A. The stability of the Seasonal Pattern Assessment Questionaire score idex over time and the validity compared to classification according to the DSM-IIIR. J Affect Disord 2003;74:167-172.
55. BECH P, KASTRUP M, RAFAELSEN OJ. Mini-compendium of rating scales for states of anxiety, depression, mania, and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 1986:73(Suppl. 326):7-37.
56. BECH P, ALLERUP P, GRAM LF et al. The Hamilton Depression Scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290-299.
57. O'SULLIVA RL, FAVA M, AGUSTIN C, BAER L, ROSENBAUM JF. Sensitivity of the six item Hamilton Depression Rating Scale. Acta Psychiatr Scand 1997;95:379-384.
58. BECH P. The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 2002;106:252-264.
59. LINGJÆRDE O, AHLFORS UG, BECH P, DENCKER SJ, ELGEN K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. 1987;76(Suppl.):334.
60. BECH P, RASMUSSEN NA, OLSEN LR, NOERHOLM V, ABILDGAARD W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001;66:159-164.
61. OLSEN LR, JENSEN DV, NOERHOLM V, MARTINY K, BECH P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003;33:351-356.
62. BECH P. Rating scales for psychopathology, health status and quality of life. A compendium on documentation in accordance with the DSM-III-R and WHO systems. Berlin: Springer, 1993.
63. OLSEN LR, MORTENSEN EL, BECH P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand 2004;110:225-229.
64. BROWN H, PRESCOTT R. Applied mixed models in medicine. Chichester: Wiley, 1999.
65. STASSEN HH, DELINI-STULA A, ANGST J. Time course of improvement under antidepressant treatment. A survival analytical approach. Eur Neuropsychopharmacol 1993;3:127-135.
66. PETO R, PIKE MC, ARMITAGE P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples, examples. Br J Cancer 1977;35:1-39.
67. SIEGEL S, CASTELLAN NJ. Non-parametric statistics for the behavioral sciences. New York: McGraw Hill, 1986.
68. FAYERS PM, MACHIN D. Quality of life. Assessment, analysis and interpretation. London: Wiley, 2000.
69. OLSEN LR, MORTENSEN EL, BECH P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 2004;109:96-103.
70. RASMUSSEN AN, NORHOLM V, BECH P. The internal and external validity of "The Psychological General Well-Being Schedule" (PGWB). Quality of Life Newsletter 1999;22:7.
71. MARTINY K, SIMONSEM C, LUNDE M, CLEMMENSEN L, BECH P. Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD). J Affect Disord 2004;79:253-257.
72. WINKLER D, PRASCHAK-RIEDER N, WILLEIT M et al. Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics. Nervenarzt 2002;73:637-643.
73. DAM H, JAKOBSEN K, MELLERUP E. Prevalence of winter depression in Denmark. Acta Psychiatr Scand 1998;97:1-4.
74. TERMAN M, AMIRA L, TERMAN JS, Ross DC. Predictors of response to light treatment for winter depression. Am J Psychiatry 1996;153:11.
75. RICKELS K, LIPMAN RS, GARCIA CR, FISHER E. Evaluating clinical improvement in anxious outpatients. Am J Psychiatry 1972;128:1005-1009.
76. BECH P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004;32:15-16.
77. BECH P. Should social functioning be an outcome in trials of antidepressants. CNS Drugs 2004 (in press).
78. TERMAN JS, TERMAN M, SCHLAGER D et al. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacology Bulletin 1990;26:3-11.
79. RIEMANN D, VODERHOLZER U, BERGER M. Sleep and sleep-wake manipulations in bipolar depression. Neuropsychobiology. 2002;45(Suppl. 1):7-12.
80. JOFFE RT, SINGER W. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry 1990;23:67-69.
81. JOFFE R, SEGAL Z, SINGER W. Change in thyroid hormone levels following response to cognitive therapy for major depression. Am J Psychiatry 1996;153:411-413.
82. JOFFE RT, LVITT AJ. (eds) The thyroid and depression. The thyroid axis and psychiatric illness. Washington DC: American Psychiatric Press, 1993:195-253.
83. BECH P. A case report showing that subclinical hypothyroidism rather than hyperthyroidism stabilizes rapidly cycling bipolar illness. Psychother Psychosom 2000;69: 110-111.
84. BENEDETTI F, COLOMBO C, PONTIGGIA A, BERNASCONI A, FLORITA M, SMERALDI E. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry 2003;64:648-653.
85. FRITZSCHE M, HELLER R, HILL H, KICK H. Sleep deprivation as a predictor of response to light therapy in major depression. J Affective Disorder 2001;62:207-215.
86. HORNE, JA, ÖSTBERG, O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. International Journal of Chronobiology 1976;4:97-110.
87. TERMAN M, WHITE TM, JACOBS J. Automated morningness-eveningness questionnaire. Self-assessment version. Norwood, NJ: Center for Environmental Terapeutics 2004. Available at: http://www.cet.org
88. HOLSBOER-TRACHSLER E, HEMMETER M, HATZINGER E, SEIFIRTZ U, GERHAR, HOBI V. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - neurobiological and psychometric assessment of course. J Psychiatr Research 1994;28:381-399.
89. BERGER, M, GASTPAR, M. Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psy Clin Neuroscience 1996;246:235-239.
90. BEAUCHEMIN KM, HAYS P. Phototherapy is a useful adjunct in the treatment of depressed in-patients. Acta Psychiatr Scand 1997;95:424-427.